SAM
WHWK

Scion Asset Management’s Whitehawk Therapeutics WHWK Stock Holding History

Scion Asset Management’s Portfolio WHWK Stock Details WHWK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-66,667
Closed -$1.29M – 37
2021
Q1 		$1.29M Buy
+66,667
New +$1.53M 0.1% 30

Other funds holding WHWK

AIM
Alerce Investment Management Chicago, Illinois $56.8M AUM 31.17% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
AICPI
ABG Innovation Capital Partners III Central, Hong Kong, Hong Kong $64.5K AUM 1.01% 1-Year Est. Return

Scion Asset Management's WHWK Position: Q2 2021 in Review

Scion Asset Management sold out of Whitehawk Therapeutics (WHWK) in Q2 2021, closing a stake of 66,667 shares — an estimated $1.29M sold.

Scion Asset Management first reported a position in WHWK in Q1 2021 and held it in 1 quarter. The position peaked at $1.29M in Q1 2021. 42 funds tracked by Wall St. Rank hold WHWK as of Q2 2021.

  • Scion Asset Management reported no remaining Whitehawk Therapeutics position as of Q2 2021 after selling out during the quarter.
  • Scion Asset Management sold 66,667 Whitehawk Therapeutics shares in Q2 2021, an estimated $1.29M.
  • Scion Asset Management first reported a position in Whitehawk Therapeutics in Q1 2021 and held it in 1 quarter.
  • Scion Asset Management's Whitehawk Therapeutics position peaked at $1.29M in Q1 2021.
  • 42 funds tracked by Wall St. Rank held Whitehawk Therapeutics as of Q2 2021.

Based on Scion Asset Management's 13F filing for Q2 2021, filed 16 Aug 2021.